Paragon 28 Inc (FNA)
6.54
+0.10
(+1.55%)
USD |
NYSE |
Sep 27, 16:00
6.56
+0.02
(+0.31%)
After-Hours: 20:00
Paragon 28 SG&A Expense (Annual): 180.02M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 180.02M |
December 31, 2022 | 159.32M |
December 31, 2021 | 114.09M |
Date | Value |
---|---|
December 31, 2020 | 72.64M |
December 31, 2019 | 74.44M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
72.64M
Minimum
2020
180.02M
Maximum
2023
120.10M
Average
114.09M
Median
2021
SG&A Expense (Annual) Benchmarks
Outset Medical Inc | 141.46M |
Perspective Therapeutics Inc | 21.06M |
Retractable Technologies Inc | 20.01M |
Xtant Medical Holdings Inc | 64.29M |
Catheter Precision Inc | 17.12M |